Exogenous growth hormone attenuates cognitive deficits induced by intermittent hypoxia in rats
Autor: | Mireille Raccurt, Richard C. Li, David Gozal, Shang Z. Guo, Elara Moudilou, Gérard Morel, Kenneth R. Brittian |
---|---|
Přispěvatelé: | Department of Pediatrics, University of Chicago, University of Louiville, Écophysiologie, Comportement, Conservation, Laboratoire d'Ecologie des Hydrosystèmes Naturels et Anthropisés (LEHNA), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-École Nationale des Travaux Publics de l'État (ENTPE)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-École Nationale des Travaux Publics de l'État (ENTPE), INSERM U365, Faculté de Médecine Laennec, Mécanisme Moléculaire du Diabète (MMD), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM), university of louis ville, University of Louis Ville, Equipe 4, Centre de Recherche en Cancérologie de Lyon (CRCL), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), University of Louisville-Kosair Children's Hospital Research Institute, Department of Pharmacology and Toxicology, University of Louisville, Université de Lyon-Université de Lyon-École Nationale des Travaux Publics de l'État (ENTPE)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-École Nationale des Travaux Publics de l'État (ENTPE)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS) |
Jazyk: | angličtina |
Rok vydání: | 2011 |
Předmět: |
Male
Vascular Endothelial Growth Factor A MESH: Hippocampus MESH: Insulin-Like Growth Factor I MESH: Anoxia Growth hormone receptor MESH: Rats Sprague-Dawley Hippocampal formation Hippocampus Rats Sprague-Dawley chemistry.chemical_compound sleep disordered breathing 0302 clinical medicine MESH: Caspase 3 neurocognitive dysfunction MESH: Animals Insulin-Like Growth Factor I Hypoxia 0303 health sciences Glucose Transporter Type 1 MESH: Heme Oxygenase-1 Caspase 3 General Neuroscience Intermittent hypoxia 3. Good health Vascular endothelial growth factor Vascular endothelial growth factor A medicine.symptom MESH: Receptors Somatotropin medicine.drug medicine.medical_specialty MESH: Rats [SDV.CAN]Life Sciences [q-bio]/Cancer Article 03 medical and health sciences Internal medicine medicine Animals Humans MESH: Erythropoietin Maze Learning Erythropoietin 030304 developmental biology MESH: Humans business.industry MESH: Maze Learning MESH: Vascular Endothelial Growth Factor A Receptors Somatotropin Hypoxia (medical) MESH: Male Rats Disease Models Animal MESH: Cognition Disorders Endocrinology chemistry MESH: Growth Hormone growth hormone MESH: Disease Models Animal [SDE.BE]Environmental Sciences/Biodiversity and Ecology business Cognition Disorders 030217 neurology & neurosurgery Heme Oxygenase-1 Hormone MESH: Glucose Transporter Type 1 |
Zdroj: | Neuroscience Neuroscience, Elsevier-International Brain Research Organization, 2011, 24, pp.196-237. ⟨10.1016/j.neuroscience.2011.08.029⟩ Neuroscience, Elsevier-International Brain Research Organization, 2011, 196, pp.237-50. ⟨10.1016/j.neuroscience.2011.08.029⟩ |
ISSN: | 0306-4522 1873-7544 |
DOI: | 10.1016/j.neuroscience.2011.08.029⟩ |
Popis: | International audience; Sleep disordered breathing (SDB), which is characterized by intermittent hypoxia (IH) during sleep, causes substantial cardiovascular and neurocognitive complications and has become a growing public health problem. SDB is associated with suppression of growth hormone (GH) secretion, the latter being integrally involved in the growth, development, and function of the CNS. Since GH treatment is able to attenuate neurocognitive deficits in a hypoxic-ischemic stroke model, GH, GH receptor (GHR) mRNA expression, and GH protein expression were assessed in rat hippocampus after exposures to chronic sustained hypoxia (CH, 10% O(2)) or IH (10% O(2) alternating with 21% O(2) every 90 s). In addition, the effect of GH treatment (50 μg/kg daily s.c. injection) on erythropoietin (EPO), vascular endothelial growth factor (VEGF), heme oxygenase-1 (HO-1), and GLUT-1 mRNA expression and neurobehavioral function was assessed. CH significantly increased GH mRNA and protein expression, as well as insulin-like growth factor-1 (IGF-1). In contrast, IH only induced a moderate increase in GH mRNA and a slight elevation in GH protein at day 1, but no increases in IGF-1. CH, but not IH, up-regulated GHR mRNA in the hippocampus. IH induced marked neurocognitive deficits compared with CH or room air (RA). Furthermore, exogenous GH administration increased hippocampal mRNA expression of IGF-1, EPO, and VEGF, and not only reduced IH-induced hippocampal injury, but also attenuated IH-induced cognitive deficits. Thus, exogenous GH may provide a viable therapeutic intervention to protect IH-vulnerable brain regions from SDB-associated neuronal loss and associated neurocognitive dysfunction. |
Databáze: | OpenAIRE |
Externí odkaz: |